A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk

European Journal of Epidemiology

Volumn 28, Issue 8, 2013, Pages 677-688

  Baltar, Valéria Troncoso ^a,b   Xun, Wei W ^b   Johansson, Mattias ^c   Ferrari, Pietro ^c   Chuang, Shu Chun ^b   Relton, Caroline ^d   Ueland, Per Magne ^e,f   Midttun, Øivind ^g   Slimani, Nadia ^c   Jenab, Mazda ^c   Clavel Chapelon, Françoise ^h,i,j   Boutron Ruault, Marie Christine ^h,i,j   Fagherazzi, Guy ^h,i,j   Kaaks, Rudolf ^k   Rohrmann, Sabine ^k   Boeing, Heiner ^l   Weikert, Cornelia ^l   Bueno De Mesquita, Bas ^m   Boshuizen, Hendriek ^m   Van Gils, Carla H ⁿ   Onland Moret, N Charlotte ⁿ   Agudo, Antonio ^o   Barricarte, Aurelio ^p,t   Navarro, Carmen ^q,t   Rodríguez, Laudina ^r   Castaño, José Maria Huerta ^s,t   Larrañaga, Nerea ^t,u   Khaw, Kay Tee ^v   Wareham, Nick ^w   Allen, Naomi E ^x   Crowe, Francesca ^x   Gallo, Valentina ^b   Norat, Teresa ^b   Krogh, Vittorio ^y   Masala, Giovanna ^z   Panico, Salvatore ^aa   Sacerdote, Carlotta ^ab   Tumino, Rosario ^ac   Trichopoulou, Antonia ^ad,ae   Lagiou, Pagona ^ad,af   Trichopoulos, Dimitrios ^af,ag   Rasmuson, Torgny ^ah   Hallmans, Göran ^ah   Roswall, Nina ^ai   Tjønneland, Anne ^ai   Riboli, Elio ^b   Brennan, Paul ^c   Vineis, Paolo ^ab,aj   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculty of Medicine   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BERGEN   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g BEVITAL AS   (Norway)

^h INSERM   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^p INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^q Regional Council of Health and Consumer Affairs   (Spain)

^r Health and Health Care Services Council   (Spain)

^s Murcia Regional Health Authority   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u Epidemiology Unit   (Spain)

^v UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^x UNIVERSITY OF OXFORD   (United Kingdom)

^y NATIONAL CANCER INSTITUTE   (Italy)

^z CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^aa UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ab Human Genetics Foundation   (Italy)

^ac CIVILE M P AREZZO HOSPITAL   (Italy)

^ad UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ae HELLENIC HEALTH FOUNDATION   (Greece)

^af HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ag BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ah UMEÅ UNIVERSITY   (Sweden)

^ai INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^aj IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

B vitamins; Folate; Immune markers; Lung cancer; Methionine; Structural equation model

Indexed keywords

BIOLOGICAL MARKER; COTININE; CYANOCOBALAMIN; CYSTATHIONINE; CYSTEINE; FOLIC ACID; GLYCINE; HOMOCYSTEINE; IMMUNE MARKER; KYNURENINE; METHIONINE; NEOPTERIN; PYRIDOXINE; RIBOFLAVIN; SERINE; TRYPTOPHAN; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AMINO ACID METABOLISM; ARTICLE; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; EXPOSURE; HUMAN; IMMUNE ACTIVATION; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; NUTRIENT; SMOKING; STRUCTURAL EQUATION MODELING; TOBACCO;

BIOLOGICAL MARKERS; FOLIC ACID; HUMANS; LUNG NEOPLASMS; MALE; METHIONINE; MODELS, STATISTICAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B COMPLEX;

EID: 84884354784     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9793-z     Document Type: Article

References (45)

1. World Health Organization. In: Cancer. Fact sheet N°297. 2012. http://www.who.int/mediacentre/factsheets/fs297/en. Accessed 25 Aug 2012.
2. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. Br Med J. 1950;2:739-48.
3. Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. PNAS. 2006;103(47):17589-94.
4. Hartman TJ, Woodson K, Stolzenberg-Solomon R, Virtamo J, Selhub J, Barrett MJ, Albanes D. Association of the b-vitamins pyridoxal 5′-phosphate (b6), B12, and folate with lung cancer risk in older men. Am J Epidemiol. 2001;153(7):688-94.
5. Johansson M, Van Guelpen B, Vollset SE, Hultdin J, Bergh A, Key T, Midttun O, Hallmans G, Ueland PM, Stattin P. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating b vitamins and metabolites. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1538-43.
6. Ulrich CM, Reed MC, Hijhout HF. Modeling folate, one-carbon metabolism, and DNA methylation. Nutr Rev. 2008;66(1):S27-30.
7. Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JF 3rd, Shane B, James SJ, Reed MC, Nijhout HF. Mathematical modelling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1822-31.
8. Johansson M, Relton C, Ueland PM, Vollset SE, Midttun Ø, Nygård O, Slimani N, Boffetta P, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Rohrmann S, Boeing H, Weikert C, Bueno-de-Mesquita HB, Ros MM, van Gils CH, Peeters PH, Agudo A, Barricarte A, Navarro C, Rodríguez L, Sánchez MJ, Larrañaga N, Khaw KT, Wareham N, Allen NE, Crowe F, Gallo V, Norat T, Krogh V, Masala G, Panico S, Sacerdote C, Tumino R, Trichopoulou A, Lagiou P, Trichopoulos D, Rasmuson T, Hallmans G, Riboli E, Vineis P, Brennan P. Serum B vitamin levels and risk of lung cancer. JAMA. 2010;303(23):2377-85.
9. Robertson CE, Vineis P. Biomarkers for nutrient-gene interactions. In: Choi S-W, Friso S, editors. Nutrient-gene interactions in cancer. Boca Raton: CRC Press; 2006. p. 37-55.
10. Choi S-W, Friso S. Interaction between folate and methylene- tetrahydrofolate reductase gene in cancer. In: Choi S-W, Friso S, editors. Nutrient-gene interactions in cancer. Boca Raton: CRC Press; 2006. p. 57-85.
11. Lee MS, Asomaning K, Su L, Wain JC, Mark EJ, Christiani DC. MTHFR polymorphisms, folate intake and carcinogen DNA adducts in the lung. Int J Cancer. 2012;131:1203-9.
12. Das PM, Signal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-42.
13. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-46.
14. Ulrich CM, Potter JD. Folate and cancer - timing is everything. JAMA. 2007;297(21):2408-9.
15. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut. 2006;55(10):1387-9.
16. Bassett JK, Hodge AM, English DR, Baglietto L, Hopper JL, Giles GG, Severi G. Dietary intake of B vitamins and methionine and risk of lung cancer. Eur J of Clin Nutr. 2012;66(2):182-7.
17. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev. 2006;15(2):189-93.
18. Leklen JE. Vitamin B6. In: Ziegler EE, Filer Jr LJ, editors. Present Knowledge in nutrition. Washington: ILSI Press; 1996. p. 174-83.
19. Davis SR, Quinlivan EP, Stacpoole PW, Gregory JF 3rd. Plasma glutathionine and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women. J Nutr. 2006;136:373-8.
20. Price JM, Brown RR, Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab disord. 1965;2:159-225.
21. Murray MF. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect Dis. 2003;3:644-52.
22. Boasso A, Vaccari M, Hryniewics A, Fuchs D, Nacsa J, Cecchinato V, Andersson J, Franchini G, Shearer GM, Chougnet C. Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J Virol. 2007;81:11593-603.
23. Moreau M, Lesgate J, Verrier D, Mormed C, Kelly KW, Castanon N. Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis. 2005;192:537-44.
24. Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun. 2002;70:859-68.
25. Melchior D, Sève B. Le Floc'h N. Chronic lung inflammation affects plasma amino acid concentration in pigs. J Anim Sci. 2004;82:1091-9.
26. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3(2):175-87.
27. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003;52(8):313-21.
28. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010;287(1):13-22.
29. Vaissière T, Cuenin C, Paliwal A, Vineis P, Hoek G, Krzyzanowski M, Airoldi L, Dunning A, Garte S, Hainaut P, Malaveille C, Overvad K, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Trichopoulos D, Kaladidi A, Pall D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Kumle M, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Janzon L, Jarvholm B, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Hainaut P, Herceg Z. Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. Epigenetics. 2009;4(4):221-30.
30. Paliwal A, Vaissière T, Herceg Z. Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids. Methods. 2010;52(3):242-7.
31. Vineis P, Chuang SC, Vaissière T, Cuenin C, Ricceri F. Genair-EPIC Collaborators, Johansson M, Ueland P, Brennan P, Herceg, Z. DNA Methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study. Epigenetics. 2011;6(2):195-201.
32. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. European prospective investigation cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113-24.
33. McCutcheon AL. Latent class analysis. No. 07-064. University Paper Series on Quantitative Applications in the Social Sciences. Newbury Park, CA: Sage, 1987.
34. Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Washington: Chapman & Hill/CRC; 2004.
35. Baltar VT, Xun WW, Chuang SC, Relton C, Ueland PM, Vollset SE, Midttun Ø, Johansson M, Slimani N, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Rohrmann S, Boeing H, Weikert C, Bueno-de-Mesquita HB, Boshuizen HC, van Gils CH, Peeters PH, Agudo A, Barricarte A, Navarro C, Rodríguez L, Castaño JM, Larrañaga N, Pérez MJ, Khaw KT, Wareham N, Allen NE, Crowe F, Gallo V, Norat T, Tagliabue G, Masala G, Panico S, Sacerdote C, Tumino R, Trichopoulou A, Lagiou P, Bamia C, Rasmuson T, Hallmans G, Roswall N, Tjønneland A, Riboli E, Brennan P, Vineis P. Smoking, secondhand smoke, and cotinine levels in a subset of EPIC cohort. Epidemiol Biomarkers Prev. 2011;20(5):869-75.
36. Byrne BM. Structural equation modeling with Mplus: Basic concepts, applications, and programming (Multivariate Applications Series). New York: Routledge; 2011.
37. Muthén LK, Muthén BO. Mplus User's Guide. 6th ed. Los Angeles: Muthén & Muthén; 2010.
38. MacCallum RC, Browne MW, Sugawara HM. Power analysis and determination of sample size for covariance structure modeling. Psychol Methods. 1996;1996(1):130-49.
39. Baluz K, do Carmo MGT, Rosas G. The role of folic acid on oncologic prevention and intervention: review. Revista Brasileira de Cancerologia. 2002;48(4):597-607.
40. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S-9S.
41. Piyathilake CJ, Johanning GL, Macaluso M, Whiteside M, Oelschlager DK, Heimburger DC, Grizzle WE. Localized folate and vitamin B-12 deficiency in squamous cell lung cancer is associated with global DNA hypomethylation. Nutr Cancer. 2000;37(1):99-107.
42. Selhub J. The Many Facets of Hyperhomocysteinemia: studies from the Framingham Cohorts. J Nutr. 2006;136(6):1726S-30S.
43. Scott JM. Folate and vitamin B12. Proc Nutr Soc. 1999;58(2):441-8.
44. Lee JE, Li H, Giovannucci E, Lee IM, Selhub J, Stampfer M, Ma J. Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1197-202.
45. Brunner J, Austin PC. Inflation of type I error rate in multiple regression when independent variables are measured with error. Can J Stat. 2009;37(1):33-46.